3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy
NCT: NCT07641764 · ACTIVE_NOT_RECRUITING
Brief Summary
Diabetic neuropathy is a condition caused by chronic high blood glucose levels that damage nerves over time, frequently causing abnormal plantar pressure and increasing the risk of foot ulcers and impaired mobility. Insoles are widely used to redistribute pressure and improve comfort. This study compares the effect of 3D printed customized insoles versus ready-to-wear insoles on plantar pressure changes in patients with diabetic neuropathy. The study is a randomized controlled trial with 22 participants randomly allocated to two groups: one receiving 3D printed customized insoles and the other receiving ready-to-wear insoles. Plantar pressure is measured using piezoresistive sensors and an Arduino Nano Unit. Secondary outcomes include foot health status (FSHQ questionnaire), satisfaction with assistive technology (QUEST 2.0), and neuropathy severity (NSS and NDS questionnaires). Assessments occur at baseline, 4 weeks, and 8 weeks.
Frequently Asked Questions
What is 3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy?
3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy is a clinical trial registered under NCT07641764. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07641764?
The current status of NCT07641764 (3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy) is: ACTIVE_NOT_RECRUITING.
When did 3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy start?
3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy started on 2026-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.